Chicago

Loading Map....

Date/Time
Date(s) - July 17,2020 - July 19,2020
8:00 am - 1:00 pm

Location
Westin Michigan Avenue Chicago

Category(ies)


HOTEL  INFO:  please call us to assist with your reservation
Westin Michigan Avenue Chicago $209 per night, single or double occupancy
www.marriott.com/hotels/travel/chiwi-the-westin-michigan-avenue-chicago

Friday July 17, 2020

Gregory Holmquist, Pharm.D., BCOP
Pain and Palliative Care Specialist

Dr. Holmquist is on the Board of Advisors of the American Society of Pain Educators. Over the past decade, he has been invited to present over 1,000 CME and CE lectures on pain management across the country. He shares practical and relevant clinical information, with a touch of humor, ensuring that audiences not only listen but also hear an important message on managing pain and making a difference in the lives of their patients.

PILLS, PEOPLE, & PAIN: UNDERSTANDING THE PROBLEM-FINDING THE SOLUTION

ACPE #   TBA

Objectives:
1.  State three myths and barriers to providing effective use of pharmacological therapies for pain control in patients.
2.  State five features of patients that differentiate patients with acute versus chronic pain syndromes.
3.  Differentiate addiction, dependence, tolerance, pseudoaddiction, pseudotolerance, and hyperalgesia.
4.  Recommend and effectively utilize standard and innovative pharmacological strategies to effectively palliate uncontrolled pain.
5.  State the role of selected co-analgesic and adjuvant pain therapies (e.g. antidepressants, anticonvulsants, NSAIDs, topical approaches) in the management of pain.
6.  Compare and contrast the pharmacology, pharmacokinetics, side effects and clinical utilization of the commercially available opioid products.
7.  Recognize the patient / chronic pain syndrome which can receive the greatest potential benefit from a trial of opioid therapy and be able to implement this therapeutic approach in a manner that minimize the risks of drug diversion, addiction, and side effects.
8.  State the common side effects associated with pain medications and be able to recommend strategies to prevent the side effects from impacting the patients’s quality of life.
——————————————————————————————————————————————————

Dr. Stan Louie, Pharm D.

University of Southern California

Dr. Stan Louie received his Doctorate in Pharmacy from the University of California in San Francisco. He continued his postgraduate work at Pacific Presbyterian Medical Center in San Francisco where he was a pharmacy resident. In addition to clinical training, he continued his basic science training at the Kuzell Institute, where he served as Associate of Research in Molecular Biology. Following his training at Kuzell, he joined USC where he continued his work on cytokine regulation in relation to tumor and/or viral proliferation at the Kenneth Norris Cancer Research Institute. Presently, he is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include HIV and hepatitis B & C.  In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.

Saturday July 18, 2020

ADVANCES IN PULMONARY DISEASES

ACPE# 0043-9999-17-055-L01-P

Objectives:

  1.  Review and identify the mechanisms associated with pulmonary disease.
  2.  Compare and contrast the mechanisms of various pharmacotherapeutic agents for the treatment of asthma and COPD.
  3.  Identify both clinical and laboratory values advocating the initiation of pulmonary therapy.
  4.  Understand and be able to manage the various adverse effects associated with pulmonary diseases.

———————————————————————————————————————————————–

Sunday July 19, 2020 

ADVANCES IN THE TREATMENT OF HEPATITIS B & C

ACPE# TBA

Objectives:

1.  Explain the risk factors of Hepatitis B & C

2.  Develop a pharmaceutical care plan that will effectively manage patients with either Hepatitis B or C infections.

3.  Identify the classes of pharmaceutical agents that are active against Hepatitis B or C.

4.  Be able to manage drug-induced toxicity associated with the treatment of Hepatitis B or C.

 

Bookings

Ticket Type Price Spaces
Chicago 3 days
15 hours of credit
$450.00
Chicago 2 days
10 hours of credit
$350.00
Chicago 1 day
5 hours of credit
$175.00

Yes
No

I am a past attendee
Facebook
Fax
Magazine
Internet
Friend


Don't have a Paypal account? You do not need a Paypal Account to pay with Paypal. Paypal allows you to pay online simply by entering your credit card and billing information.